News | July 26, 2023
Syngene Q1 FY 2024 revenue up 26% to Rs. 832 crores, PAT up 26% to Rs.93 Cr
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
Samsung Biologics will provide Pfizer with additional capacity for large-scale manufacturing for a multi-product biosimilars portfolio
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists
Fully equipped labs with 75-member team set-up and made operational in <100 days
MoU signed between AIIA and University of Amrita Vishwa Vidhyapeetham for collaboration in the field of Research and Academics in Ayurveda
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
Ayurveda is one of the most advanced sciences of its times
Subscribe To Our Newsletter & Stay Updated
